AzTrials
AzTrials

Circulatory FailureFASTNCT07522580

Fluid-responsiveness Assessment Simplified by Electric Cardiometry in Children

An observational study of Circulatory Failure and Shock State, run by University Hospital, Bordeaux at 4 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In this study of diagnostic accuracy, the investigators aim to validate a faster, simpler, and noninvasive test of fluid-responsiveness in critically ill children. This test is based on an assessment of the hemodynamic effects of a standardized abdominal compression, using electrical cardiometry. Read more about this study

Who is it for?
Ages 0 days to 8 years
Conditions the study is for
Circulatory Failure, Shock State, Fluid Therapy
What is being tested?
validation a test of fluid-responsiveness in critically ill children
How many people
42 participants
Where
4 sitesFrance
Study dates
22 Jul 2025to 19 Aug 2027
How long will I take part?
28 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 days to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: patient hospitalised in intensive care or in a continuous monitoring unit

Who may be able to join

  • Age less than or equal to 8 years old
  • Hospitalization in a pediatric intensive care unit
  • Prescription by the attending physician of a fluid expansion of 10ml/kg
  • Use of a non-invasive cardiac output monitoring device (electrical cardiometry) as part of routine care

Who cannot join

  • Patient less than 37 weeks' corrected gestational age
  • Hemodynamic instability making the delay necessary for any test dangerous
  • Supine position contraindicated or deleterious
  • Impairment of echocardiographic acoustic window or restless patient making ultrasonography impossible
  • Opposition to participate expressed by the patient or by a parent or legal guardian
  • Intra-abdominal hypertension, painful abdominal palpation or abdominal surgery in the last 15 days

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France4 sites, 4 recruiting
  • Hôpital Marie Lannelongue

    Le Plessis-Robinson, France, 92350

    Angèle BOËT, MD, +33 1 40 94 85 92 ext. +33, a.boet@ghpsj.fr

    Not yet recruiting
  • Hôpital Arnaud de Villeneuve - CHU de Montpellier

    Montpellier, France, 34295

    Arthur GAVOTTO, MD, +33 4 67 33 66 26 ext. +33, a-gavotto@chu-montpellier.fr

    Not yet recruiting
  • Hôpital mère-enfant - CHU de Nantes

    Nantes, France, 44093

    Pierre BOURGOIN, MD, +33 2 76 64 36 12 ext. +33, pierre.bourgoin@chu-nantes.fr

    Not yet recruiting
  • Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux

    Pessac, France, 33600

    Julien GOTCHAC, MD, +33 5 24 54 92 19 ext. +33, julien.gotchac@chu-bordeaux.fr

    Recruiting

Other trials in France

About this study

In this study of diagnostic accuracy, the investigators aim to validate a faster, simpler, and noninvasive test of fluid-responsiveness in critically ill children. This test is based on an assessment of the hemodynamic effects of a standardized abdominal compression, using electrical cardiometry. This would help physicians to identify more easily which patient could benefit from a volume expansion, thus avoiding a potentially useless or even dangerous fluid expansion that could lead to fluid overload. To this end, the diagnostic accuracy of electrical cardiometry-based stroke volume (SV) variation induced by a standardized abdominal compression to predict fluid responsiveness (define as a 15% increase in echocardiographically measured SV after volume expansion) will be measured.

Read the detailed description

Volume expansion is the cornerstone of acute circulatory failure treatment in children. However, inappropriate administration can lead to fluid overload, which is associated with poor outcome. Thus, the search for indicators to predict fluid responsiveness is a major issue in pediatric intensive care unit. In such an emergency context, this assessment must be as simple and fast as possible, and ideally non-invasive. In children, respiratory variability of peak aortic velocity is the most studied test and has an excellent diagnostic accuracy but is only validated in the absence of any spontaneous respiratory movement, a rare situation in practice. Recently, the abdominal compression maneuver has been investigated. This classical clinical maneuver induces a transient and reversible preload increase by increasing the venous return via the mobilization of the hepato-splanchnic venous reservoir. The echocardiographic evaluation of this maneuver can accurately predict fluid responsiveness. However, this echocardiographic assessment is a pitfall, as it is an operator-dependent, discontinuous and time-consuming examination. Therefore, electrical cardiometry could be interesting. This continuous and non-invasive cardiac output monitor could be an interesting alternative to evaluate the hemodynamic effects of the abdominal compression maneuver in order to predict fluid responsiveness.

Therefore, the investigators will evaluate the diagnostic accuracy of an abdominal compression maneuver for the diagnosis of fluid responsiveness in critically ill children, for whom the physician in charge prescribed a 10ml/kg volume expansion for circulatory failure. The index test will be the SV variation induced by an abdominal compression maneuver, with SV being measured with electrical cardiometry. Fluid responsiveness will be defined as a > 15% increase in echocardiographically-measured SV between baseline and within one hour after fluid expansion (gold standard test).

In this non-interventional, prospective, multi-center study of diagnostic accuracy, children requiring a 10ml/kg volume expansion will be included. After a prescription of 10 ml/kg volume expansion by the physician in charge, screening for inclusion and exclusion criteria will be performed by an investigator physician. If the patient is included, volume expansion will be delayed for a few minutes (<3 min) while an echocardiography and the index test are performed, but no supplemental blood test or invasive parameters will be collected. Another echocardiographic evaluation will be conducted within one hour after volume expansion, to assess response to fluid expansion (gold-standard test). Patients will be follow-up until PICU discharge (28 days maximum).

The index test is the ΔSV-ACICON: percentage of SV variation between baseline and during a standardized abdominal compression. Stroke volume will be assessed by electrical cardiometry, a noninvasive cardiac output monitoring.

The abdominal compression maneuver, a common clinical test in critically ill children, will be standardized as follow: a sphygmomanometer will be inflated with 80ml of air and will be applied to the center of the patient's abdomen. Then, the operator's hand will be placed on the sphygmomanometer (which is thus interposed between the patient's abdomen and the operator's hand) and a gentle manual anteroposterior compression will be performed, calibrated at 30 cmH2O according to the sphygmomanometer. Parameters of interest will be collected 30 seconds after the start of the compression.

Patients included in this study would have received volume expansion anyway, as the prescription of 10ml/kg volume expansion by the physician in charge is the main inclusion criterion. The purpose of this study is to evaluate the diagnostic accuracy of a fluid responsiveness test. To this end, patients:

  • Will undergo echocardiographic assessments, which is noninvasive, non-radiative, well tolerated and commonly used in this population as a standard of care in our center.
  • Will undergo a standardized abdominal compression, a commonly used maneuver in our center and in other pediatric intensive care units, which differs only slightly from a standard physical examination.
  • No additional blood test or invasive parameters will be collected be collected. Number of subjects: Forty-two patients are needed. This was calculated with an alpha risk of 0.05, an expected prevalence of 0.5, a predicted area under the receiver operating characteristics curve of 0.90 (based on previous studies) and a width of the 95% confidence interval narrow enough to exclude 0.80 which is a threshold for clinical relevance.

Statistical analysis: Comparisons between fluid "responders" and "non-responders" will be performed with Student's t-test or Mann-Whitney test for continuous variables; or with the Chi-2 test or Fisher's exact test for categorical variables. Spearman correlation coefficient will be used to test linear correlations.

Fluid responsiveness represents the gold standard test. Patients will be classified as fluid responders in case of at least 15% increase in SV after fluid expansion, compared to baseline.

Diagnostic accuracy of the index tests will be explored. As multiple cut-offs of theses index tests can be defined, the investigators will report a receiver operating characteristic (ROC) curve which graphically represents the combination of sensitivity and specificity for each possible test positivity threshold. The area under the ROC curve and its 95% confidence interval informs in a single numerical value about the overall diagnostic accuracy of the index test. The ROC curves of all index tests will be compared using a DeLong test.

A p value less than 0.05 will be considered statistically significant

Being tested
validation a test of fluid-responsiveness in critically ill children
Keywords
Circulatory failure, Critical Care, Echocardiography, Electrical Cardiometry, Fluid therapy, Fluid responsiveness, Goal-directed fluid management, pediatrics, volume expansion
Medical subject headings
Shock

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • validation a test of fluid-responsiveness in critically ill childrenDiagnostic test

    This test is based on an assessment of the hemodynamic effects of a standardized abdominal compression, using electrical cardiometry.

Study groups in NCT07522580
Study groupRoleWhat they receive
Patient in paediatric intensive care unitNot described
Receives: Diagnostic Test: validation a test of fluid-responsiveness in critically ill children

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Area under the ROC curve (AUROC, %) of ΔSV-ACICON to diagnose fluid responsiveness

    Description: The primary outcome measure of a diagnostic accuracy study is the discriminative ability of an index test (expressed as an area under the ROC curve) to diagnose a condition (defined by a positive gold-standard reference test). In this study:

    • The index test is ΔSV-ACICON = difference between stroke volume measured by electrical cardiometry (ml) during a calibrated abdominal compression (30mmHg for 30 seconds) and stroke volume measured by electrical cardiometry at baseline.
    • The condition is "fluid responsiveness"
    • The gold-standard reference test to diagnose fluid responsiveness is a stroke volume (SV) increase of at least 15% between baseline and after volume expansion: ΔSV-VE > 15% = ((SV after volume expansion - SV at baseline) / SV at baseline) > 15%. SV (ml) will be measured by transthoracic echocardiography as the product of left ventricular outflow tract surface (cm², from a parasternal long axis view) and left ventricular outflow tract velocity-time integral

    Measured: between baseline and 1 hour

Secondary outcomes (27)
  1. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Respiratory variability of peak aortic velocity at baseline (%)

    Measured: between baseline and 1 hour

  2. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Respiratory variability of inferior vena cava diameter at baseline (%)

    Measured: between baseline and 1 hour

  3. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Stroke volume respiratory variations at baseline (%), measured with electrical cardiometry

    Measured: between baseline and 1 hour

  4. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Abdominal compression induced variations in arterial pressure (%)

    Measured: between baseline and 1 hour

  5. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Abdominal compression induced variations in perfusion index (%)

    Measured: between baseline and 1 hour

  6. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Abdominal compression induced variations in end-tidal carbon dioxide (%)

    Measured: between baseline and 1 hour

  7. AUROC (%) of the following index test to diagnose fluid responsiveness (same definition as above )

    Abdominal compression induced variations in arterial pulse pressure variability index (%)

    Measured: between baseline and 1 hour

  8. Diagnostic accuracy (AUROC, %) of all tests above to diagnose a significant increase (>15%) in mean arterial pressure after volume expansion

    Measured: between baseline and 1 hour

  9. Subgroup analysis of the primary outcome: age, type of fluid expansion, ventilation status, circulatory physiology

    Measured: between baseline and 1 hour

  10. Correlation between fluid responsiveness and the following.

    Age category (0 - 2 years / 2 - 8 years)

    Measured: At baseline; 1 hour ; Day 28.

  11. Correlation between fluid responsiveness and the following.

    Reason for intensive care admission (cardiac surgery, univentricular circulation / cardiac surgery, biventricular circulation / other)

    Measured: At baseline; 1 hour ; Day 28.

  12. Correlation between fluid responsiveness and the following.

    Sex

    Measured: At baseline; 1 hour ; Day 28.

  13. Correlation between fluid responsiveness and the following.

    Weight at baseline (kg)

    Measured: At baseline; After fluid expansion (see Primary Outcome Measure for Time Frame precise definition); Day 28.

  14. Correlation between fluid responsiveness and the following.

    Number of fluid expansion during the last 24 hours before inclusion

    Measured: At baseline; After fluid expansion (see Primary Outcome Measure for Time Frame precise definition); Day 28.

  15. Correlation between fluid responsiveness and the following.

    Baseline Heart rate (bpm)

    Measured: At baseline; After fluid expansion (see Primary Outcome Measure for Time Frame precise definition); Day 28.

  16. Correlation between fluid responsiveness and the following.

    Baseline arterial pressure (mmHg)

    Measured: At baseline; After fluid expansion (see Primary Outcome Measure for Time Frame precise definition); Day 28.

  17. Correlation between fluid responsiveness and the following.

    Baseline urine output (ml/kg/h)

    Measured: At baseline; After fluid expansion (see Primary Outcome Measure for Time Frame precise definition); Day 28.

  18. Correlation between fluid responsiveness and the following.

    Baseline capillary refill time (s)

    Measured: At baseline; After fluid expansion (see Primary Outcome Measure for Time Frame precise definition); Day 28.

  19. Correlation between fluid responsiveness and the following.

    Baseline mottling (yes/no)

    Measured: At baseline; 1 hour ; Day 28.

  20. Correlation between fluid responsiveness and the following.

    Baseline PELODS2 score (n)

    Measured: At baseline; 1 hour ; Day 28.

  21. Correlation between fluid responsiveness and the following.

    Type of volume expansion (albumin or crystalloid)

    Measured: At baseline; 1 hour ; Day 28.

  22. Correlation between fluid responsiveness and the following.

    Length of mechanical ventilation (days), evaluated 28 days after inclusion

    Measured: At baseline; 1 hour ; Day 28.

  23. Correlation between fluid responsiveness and the following.

    Intensive care unit length of stay (days), evaluated 28 days after inclusion

    Measured: At baseline; 1 hour ; Day 28.

  24. Correlation between fluid responsiveness and the following.

    Mortality at 28 days after inclusion (yes/no)

    Measured: At baseline; 1 hour ; Day 28.

  25. Correlation between fluid responsiveness and the following.

    % of increase in mean perfusion pressure (i.e. difference between mean arterial pressure and central venous pressure, mmHg) between baseline and after volume expansion

    Measured: At baseline; 1 hour ; Day 28.

  26. Correlation between fluid responsiveness and the following.

    % of increase in central venous pressure (mmHg) between baseline and after volume expansion

    Measured: At baseline; 1 hour ; Day 28.

  27. Correlation between fluid responsiveness and the following.

    % of increase in stroke volume (ml) measured by electrical cardiometry between baseline and after volume expansion

    Measured: At baseline; 1 hour ; Day 28.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2026
  2. Study start22 Jul 2025
  3. Primary completion22 Jul 2027 (estimated)
  4. Study completion19 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
42 participants (estimated)
Target duration
28 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07522580
Sponsor's protocol ID
CHUBX 2025/019
Other IDs
2025-A01029-40
Acronym
FAST
Status last verified
Mar 2026
First submitted
1 Sep 2025
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Circulatory Failure and Shock State, run by University Hospital, Bordeaux at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Julien GOTCHAC, MD (+33 5 24 54 92 19 ext. +33, julien.gotchac@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Area under the ROC curve (AUROC, %) of ΔSV-ACICON to diagnose fluid responsiveness (time frame: between baseline and 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in